Comprehensive enterprise security framework protecting pharmaceutical regulatory data with Azure AD authentication, encrypted credentials, and complete 21 CFR Part 11 audit trails.
DNXT validates every PDF against 23 compliance rules for FDA EMA submissions, eliminating technical rejections with automated validation and auto-fix capabilities.
Many life sciences companies continue to manage eCTD submissions through a patchwork of spreadsheets, shared drives, and manual processes. On the surface, this approach seems cost-effective—no software licenses, no implementation projects, no change management. But the true cost of manual submission management extends far beyond what appears on any budget line. The Hidden Costs of […]
FDA 21 CFR Part 11 compliance isn’t optional for life sciences companies managing electronic records. Yet many organizations only think about compliance when an audit is imminent—leading to stressful scrambles and potential findings. This guide provides a systematic approach to audit preparation that regulatory operations leaders can implement today. Understanding What FDA Inspectors Look For […]
Enterprise Security for Regulated Cloud Platforms: A Senior Leader’s Checklist When you propose a cloud-based regulatory platform to your organization, you will face two audiences: the business stakeholders who want faster submissions, and the IT security and quality teams who want assurance that moving regulated data to the cloud does not introduce unacceptable risk. The […]
Download the 2025 industry benchmark report for regulatory operations. Resource constraints, costs, and how leading teams are transforming.
eCTD 4.0 moves to HL7 RPS — a fundamental shift. Here’s what regulatory teams at emerging biotech need to prepare for and what to ask your vendor.
In pharmaceutical document management, data security isn’t just important—it’s mission-critical. When sensitive regulatory documents contain proprietary formulations, clinical trial data, and submission strategies worth millions, the last thing you want is that information flowing to external AI providers where you lose control forever. That’s exactly what happens with most AI-powered document solutions. Your confidential regulatory […]
The Hidden Foundation of Regulatory Success When pharmaceutical companies struggle with document management chaos, missed deadlines, and compliance nightmares, the solution isn’t just better processes—it’s better architecture. DNXT Publisher Suite’s revolutionary microservices foundation transforms how life sciences organizations handle their most critical regulatory documents, delivering unprecedented reliability, scalability, and compliance assurance. Why Architecture Matters for […]
In the high-stakes world of pharmaceutical regulatory compliance, one mismanaged document or overlooked metadata field can derail million-dollar drug approvals. Yet most organizations still struggle with fragmented document management systems that create more problems than they solve. The Hidden Cost of Metadata Mismanagement Every pharmaceutical company knows the pain: submissions delayed because documents can’t be […]
